169169 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types Cells of the immune system
Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
#602Method of treating rheumatoid arthritis with antibodies to M-CSF
#603Regulatory T-Cells Containing Galectins for the Therapy and Diagnosis of Diseases
#604Oral killed vaccines and method for providing same
#605FUNCTION HOMOLOGY SCREENING
#606Modulation of Inflammation Related to Columnar Epithelia
#607Product and method for treatment of conditions associated with receptor-desensitization
#608FUNCTION HOMOLOGY SCREENING
#609Methods for Selecting Proteins that are Readily Presented as Antigens on Dendritic Cells
#610Treatment of atherosclerosis
#611Biological dataset profiling of asthma and atopy
#612THERAPEUTIC USE FOR ALPHA1 PROTEINASE INHIBITOR IN HEMATOPOIESIS
#613METHODS, PHARMACEUTICAL FORMULATIONS AND KITS FOR IDENTIFICATION OF SUBJECTS AT RISK FOR CANCER
#614Methods for Determining the Potency, Specificity, and Toxicity of Hematopoietic Prostaglandin D2 Synthase
#615NEGATIVE IMMUNOMODULATION OF IMMUNE RESPONSES BY NKG2D-POSITIVE CD4+ CELLS
#616Compositions and methods for treatment of immune-related disease
#617Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
#618Conformational and topological protein regulation
#619In vitro germinal centers
#620Immunomodulating compositions and uses therefor
#621Methods For Diagnosing And Treating Endoplasmic Reticulum (er) Stress Diseases
#622Filoviral immunosuppressive peptides and uses thereof
#623Monocyte activation test better able to detect non-endotoxin pyrogenic contaminants in medical products
#624Visualization and quantitation of cellular cytotoxicity using cell-permeable fluorogenic protease substrates and caspase activity indicator markers
#625MODULATION OF RHAMM-CAVEOLIN/LIPID RAFT INTERACTIONS TO AFFECT DEVELOPMENT, RESPONSES TO TISSUE INJURY, ANGIOGENESIS, TUMORIGENESIS, METASTASIS AND GROWTH FACTOR/CYTOKINE RESPONSES
#626Anti-hiv-1 compounds based upon a conserved amino acid sequence shared by gp160 and the human cd4 protein
#627Methods for Detecting DNA Damage and Screening for Cancer Therapeutics
#628Diagnostic test
#629CD86 and CD80 receptor competition assays
#630METHODS OF IN VITRO PROPAGATION AND DETECTION OF INFECTIOUS PRION
#631Use of cathepsin z inhibitors for the treatment of rhuematoid arthritis and other autoimmune diseases
#632BLOCKING LEUKOCYTE EMIGRATION AND INFLAMMATION BY INTERFERING WITH CD99/HEC2
#633Cell fusions and methods of making and using the same
#634Automatable artificial immune system (AIS)
#635Effectors of innate immunity
#636Secreted neural apoptosis inhibiting proteins
#637Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
#638Hematopoietic progenitor kinase 1 for modulation of an immune response
#639Methods of treatment and diagnosis using modulators of virus-induced cellular gene sequences
#640Method to detect antigen-specific cytolytic activity
#641Gamma secretase notch biomarkers
#642Compositions and methods for suppressing fibrocytes and for detecting fibrocyte differentiation
#643Process for evaluating phagocytotic function and use thereof
#644Methods of screening for immuno-adjuvants and vaccines comprising anti-microtubule immuno-adjuvants
#645Methods for predicting drug sensitivity in patients afflicted with an inflammatory disease
#646Immune profiling of lymph nodes associated with cancer
#647Development of natural killer cells and functional natural killer cell lines
#648CD38 modulated chemotaxis
#649Purposeful movement of human migratory cells away from an agent source
#650123 human secreted proteins
#651Artificial lymphoid tissue equivalent
#652Genetically modified human natural killer cell lines
#653Antimicrobial mediated ozone generation
#654Compositions and methods for treatment of eye disorders
#655Compositions and methods for regulating NK cell activity
#656Methods utilizing target genes related to immune-mediated diseases
#657Process for characterization of the transactivation and transrepression activity of glucocorticoid receptor ligands in primary immune cells
#658Methods of using IL-21 for adoptive immunotherapy and identification of tumor antigens
#659Mast cell activation using siglec 6 antibodies
#660Interleukin-2 muteins
#661Utilization of an aminopeptidase inhibitor
#662In vitro test system for predicting patient tolerability of therapeutic agents
#663Prevention and treatment of amyloid-associated disorders
#664Modulators of leukocyte activation, compositions and methods of use
#665Methods and compositions for screening for modulators of IgE synthesis, secretion and switch rearrangement
#666Anti-CD63 antibodies and methods of use thereof
#667Method for characterizing the oxidative stress protective capacity of an antioxidative substance
#668Apoptosis marker antibodies and methods of use
#669Potent, selective and non toxic c-kit inhibitors
#670Fungal antigens and eosinophil activity
#671Combinatorial interleukin-2 muteins
#672Monocyte chemoattractant activity of galectin-3
#673Methods and compositions for screening for altered cellular phenotypes
#674Method for immunotherapy of tumors
#675Novel method of selecting immunosuppressant having little thrombocytopenic effect
#676Method for inducing complete hepatitis c virus (hcv) replication in vitro
#677Therapeutic use of farnesyltransferase inhibitors and methods of monitoring the efficacy thereof
#678Acetylated protein
#679DAP-10 and uses thereof
#680Methods of identifying compounds that modulate igg mediated mast cell activation
#681Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
#682Detecting superantigen activity in a biological sample
#683Methods of determining deficiencies in intracellular levels on cysteine and glutathione
#684Methods
#685Methods to prevent tumor recurrence by blockade of tgf-beta
#686Use of urea-adjuvated polypeptides for diagnosis, prophylaxis and treatment
#687Compound for inhibiting the influx of polymorphonuclear leukocytes (PMNs) in a tissue, its selection, pharmaceutical compositions and use
#688Methods for identification and uses of anti-inflammatory receptors for eicosapentaenoic acid analogs
#689Methods and compositions for using MHC class II invariant chain polypeptide as a receptor for macrophage migration inhibitory factor
#690Conformational and topological protein regulation
#691Drug or cosmetic
#692Screening method for identifying compounds that selectively induce interferon alpha
#693Determination of protein function
#694Methods of suppressing microglial activation
#695Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral activity
#696Wound healing dressing for enhancing fibrocyte formation
#697Methods for measurement of lymphocyte function
#698Method of measuring activation of effector cells
#699Methods and compositions related to IRM compounds and toll-like receptor pathways
#700Large-area two-dimensional non-adhesive cell arrays for sensing and cell-sorting applications
#701Methods of suppressing fibrosis and fibrocyte formation
#702Method and apparatus for automated assessment of the immunoregulatory status of the mononuclear leukocyte immune system
#703Methods for stimulating human leukocytes to kill bacteria, yeast and fungi in biofilms that have formed in/on prosthetic devices, catheters, tissues and organs in vivo
#704Use of tyrosine kinase inhibitors for treating substance use disorders
#705Genes encoding single chain human leukocyte antigen E (HLA-E) proteins to prevent natural killer cell-mediated cytotoxicity and cytotoxic T Lymphocyte (CTL)-mediated cytotoxicity
#706Method for mapping and eliminating T cell epitopes
#707Modulators of lymphocyte activation, Mkk3b compositions and methods of use
#708Cell fusions and methods of making and using the same
#709Methods of treating asthma
#710Modulation of HSV infection
#711Hsp peptides and analogs for modulation of immune responses via antigen presenting cells
#712Method of detecting immune response
#713Bioluminescent assays and cells useful therein
#714Method for analyzing effects of medical agents
#715Method for isolation and replication of infectious human hepatitis-C virus
#716Therapeutic applications for the anti-T-BAM (CD40-1) monoclonal antibody 5C8
#717Methods and compositions for risk stratification
#718Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens
#719CD200 receptors
#720Method and composition for treating immune complex associated disorders
#721In vitro model for gastrointestinal inflammation
#722Use of antibody from lymphocyte secretions to diagnose active infection
#723Induction of a Th1-like response in vitro
#724Method for identifying compounds that specifically deplete mast cells
#725Novel complementing receptor-ligand pairs and adoptive immunotherapy using the same
#726Method of selecting HLA-DP4 ligands and the applications thereof
#727Method for detecting modulators of Notch signalling
#728Selective modulation of TLR gene expression
#729Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds
#730Modulators of Notch signalling for use in immunotherapy
#731Diagnostic assay for measuring a cell mediated immune response
#732Conformational and topological protein regulation
#733Method for detecting allergies
#734Conformational and topological protein regulation
#735Conformational and topological protein regulation
#736Biological markers for evaluating therapeutic treatment of inflammatory and autoimmune disorders
#737Systems and methods for measuring changes in cellular activity in live tissue
#738Multi-functional echogenic immunoliposomes for directed stem cell delivery to atheroma